Trial intelligence / Profile preview

Rupatadine in Cold Contact Urticaria

NCT01605487Phase 2Completed

Sponsor
Charité – Universitätsmedizin Berlin
Start
Jun 2012
Primary completion
Sep 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of rupatadine in cold urticaria, sponsored by Charité – Universitätsmedizin Berlin. Started Jun 2012; status: completed.

02

Drugs

rupatadine
03

Conditions

cold urticaria

Beyond the preview

Go deeper on NCT01605487.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01605487.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call